Keynote Presentation: Clinical & Mechanistic Perspective on Bringing Cell Therapies to Autoimmune Disease

Time: 10:00 am
day: Conference Day Two P1

Details:

• Introducing RNA engineering for cell therapy
• Demonstrating deep and durable responses in patients receiving Descartes-08 without lymphodepletion or inpatient administration
• Insight into mechanisms behind Cartesian Therapeutics’ lead asset, Descartes-08

Speakers:

Christopher Jewell Dr Jewell is the company’s CSO. His expertise in bioengineering, immunology, and nanotechnology span two decades of experience, including as the MPower Professor and Minta Read more